UNASSIGNED:确定瑞典电子处方系统的问题,并制定一套建议来克服已确定的挑战。
UNASSIGNED:使用有目的和滚雪球采样,从不同来源回顾性地收集了一些与健康信息技术相关的事件。使用包含五个关键字的搜索词来识别与电子处方相关的事件。已确定的事件(n=24)受到现有框架的影响,即,健康信息技术分类系统。特别注意了与软件有关的问题,使用专题分析进行了分析。
UNASSIGNED:确定了几种类型的软件相关问题(n=22):系统配置,与其他软件系统或组件的接口,软件功能,数据存储和备份,记录迁移,软件无法访问,和网络/服务器停机或变慢。人类和技术因素都是造成这些事件的原因,包括未主动取消的处方,药物处理错误,软件编程错误,和系统更新/升级。这些软件问题导致了各种后果,例如影响多名患者护理管理的事件,病人护理的延误,以及健康严重恶化的风险。若干临时举措或行政调整,例如,给患者的求职信和当地策略,被用来克服其中的一些挑战。
UNASSIGNED:这项研究提供了与电子处方系统相关的挑战的见解,促成因素,后果,以及为减轻这些风险而采取的行动。因此,使用电子处方系统的医疗机构应采纳所提供的建议,以最大程度地减少设计和发展挑战的风险,实施和使用相关问题,以及与监控有关的问题,评估,和优化。
UNASSIGNED: To identify issues with the Swedish e-prescribing system and devise a set of recommendations to overcome the identified challenges.
UNASSIGNED: A number of health information technology-related incidents were collected retrospectively from various sources using purposive and snowball sampling. A search term containing five keywords was used to identify the electronic prescription-related incidents. The identified incidents (n = 24) were subjected to an existing framework, i.e., the Health Information Technology Classification System. Special attention was paid to the software-related issues, which were analysed using thematic analysis.
UNASSIGNED: Several types of software-related issues (n = 22) were identified: system configuration, interface with other software systems or components, software functionality, data storage and backup, record migration, software not accessible, and network/server down or slow. Both human and technical factors contributed to these incidents, including prescriptions not cancelled actively, drug handling errors, software programming errors, and system updates/upgrades. These software problems led to various consequences, such as incidents affecting multiple patients\' care management, delays in patient care, and risks of serious deterioration of health. Several temporary initiatives or administrative adjustments, for instance, cover letters to patients and local strategies, were used to overcome some of these challenges.
UNASSIGNED: This study provides insights into the challenges related to the e-prescribing system, contributing factors, consequences, and actions taken to mitigate those risks. Therefore, healthcare organisations using the e-prescribing system should adopt the provided recommendations to minimise the risks of design and developmental challenges, implementation and use-related issues, and the problems related to monitoring, evaluation, and optimisation.